Krishna P Agarwala Md is categorized under Internal Medicine Doctors in Massillon, OH and active since 1976.
Krishna P Agarwala Md was established in 1976, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Dr Krishna P Agarwala at the company’s single location by writing to 1717 Chittenden Circle Ne, Massillon, Ohio OH 44646 or by phoning (330) 493-4010. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Krishna P Agarwala Md |
| Contact Person: | Dr Krishna P Agarwala |
| Address: | 1717 Chittenden Circle Ne, Massillon, Ohio 44646 |
| Phone Number: | (330) 493-4010 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1976 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Krishna P Agarwala Md was started in 1976 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dr Krishna P Agarwala for inquiries that concern Krishna P Agarwala Md by calling the company number (330) 493-4010, as your correspondence is most welcome. Additionally, the physical location of the single location of Krishna P Agarwala Md can be found at the coordinates 40.815623,-81.505823 as well as the street address 1717 Chittenden Circle Ne in Massillon, Ohio 44646.
For its online presence, you may visit Krishna P Agarwala Md’s website at and engage with its social media outlets through on Twitter and on Facebook.